共 11 条
[1]
Henoch-Schonlein purpura. Tarvin S E,,Ballinger S. CurrentPaediatrics . 2006
[2]
Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Gardner-Medwin JM,Dolezalova P,Cummins C,et al. Lancet,The . 2002
[3]
Immunization safety surveiljance:guidelines for-managers of immumzatlon programs on reporting and investiga-tingadverse events following immunization (S). WH0,WPBO. . 1999
[4]
Ten Great Public Health Achievements——Worldwide,2001-2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6024a4.htm . 2012
[5]
Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Katrin S Kohl,Manya Magnus,Robert Ball et al. Vaccine . 2008
[6]
Standardized case defi-nitions of adverse events following immunization (AEFI).. Bonhoeffer J,Heininger U,Kohl K,et al. Vaccine . 2004
[7]
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Bonhoeffer, J,Kohl, K,Chen, R,Duclos, P,Heijbel, H,Heininger, U,Jefferson, T,Loupi, E. Vaccine . 2002
[9]
特发性血小板减少性紫癜诊断中的相关问题[J]. 胡群. 实用儿科临床杂志. 2010(03)
[10]
Henoch–Schonlein purpura[J] . S.E. Tarvin,Susan Ballinger.  Current Paediatrics . 2006 (4)